Brief: Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results, Provides Corporate Update

DMK Pharmaceuticals

14/11/2022 21:52

Nov 14 (Reuters) - Adamis Pharmaceuticals Corp  ADMP.O :
    * ADAMIS PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * ADAMIS PHARMACEUTICALS CORP - QTRLY LOSS PER SHARE $0.03
    * ADAMIS PHARMACEUTICALS CORP - QTRLY TOTAL NET REVENUE $1.5
MILLION VERSUS $760,000
    * ADAMIS PHARMACEUTICALS CORP- CASH AND CASH EQUIVALENTS AS
OF
SEPTEMBER 30, 2022 WERE APPROXIMATELY $2.4 MILLION

Source text for Eikon:  ID:nGNXmCLBB 
Further company coverage:  ADMP.O 
 ((Reuters.Briefs@thomsonreuters.com;))